Patent · US Active

Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug

US7985774B2 · kind B2 · utility

3Cited by

1References

13Claims

0Family size

Assignee

TROPHOS · FR

Inventors

Rebecca Pruss · Cassis, FR
Bruno Buisson · Marseilles, FR
Thierry Bordet · Marseilles, FR

Key dates

Filing date	Feb 23, 2007
Grant date	Jul 26, 2011
Priority date	—
Expiry date	Nov 6, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C251/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug, notably a cardioprotective or hepatoprotective drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.